Literature DB >> 15750313

Abnormal development of nephrons in claudin-16-defective Japanese black cattle.

Kosuke Okada1, Naoko Ishikawa, Kouichiro Fujimori, Masanobu Goryo, Manabu Ikeda, Jun Sasaki, Daisaku Watanabe, Akiko Takasuga, Takashi Hirano, Yoshikazu Sugimoto.   

Abstract

The kidneys of 37 Japanese Black calves aged 2 to 65 months diagnosed with Claudin 16 (CL-16) defect by the DNA-based test were examined pathologically. The animals exhibited clinical symptoms such as growth impairment, renal failure, overgrowth of hooves, and anemia at a young age. There was no correlation between the time of onset and age. Kidney weights relative to body weight were similar to those in normal animals, but both kidney net weights and size were reduced due to atrophy in animals that showed severe renal dysfunction. Histopathological examination of the kidneys showed reduction in the number of glomeruli, compensatory hypertrophy of glomeruli and tubules, and glomerular and tubular atrophy accompanied by interstitial fibrosis and lymphocytic infiltration. Glomeruli were clearly less in number in the kidneys of CL-16-defective animals than those of normal animals even in the cases with mild lesions. A small number of immature glomeruli and tubules were also detected, suggesting that there were fewer nephrons developed at birth in CL-16-defective animals. It was suggested that a defect of the CL-16 gene is involved in the "abnormal development of nephrons". Immunohistopathological examination of the kidneys showed that the epithelium of thick ascending limb of Henle was stained with anti-CL-16 antibody in the control animals, but not in the affected animals, suggesting a defect of CL-16 in the epithelium of renal tubules in the affected animals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750313     DOI: 10.1292/jvms.67.171

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  7 in total

Review 1.  Function and regulation of claudins in the thick ascending limb of Henle.

Authors:  Dorothee Günzel; Alan S L Yu
Journal:  Pflugers Arch       Date:  2008-09-16       Impact factor: 3.657

2.  Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations.

Authors:  Astrid Godron; Jérôme Harambat; Valérie Boccio; Anne Mensire; Adrien May; Claire Rigothier; Lionel Couzi; Benoit Barrou; Michel Godin; Dominique Chauveau; Stanislas Faguer; Marion Vallet; Pierre Cochat; Philippe Eckart; Geneviève Guest; Vincent Guigonis; Pascal Houillier; Anne Blanchard; Xavier Jeunemaitre; Rosa Vargas-Poussou
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-15       Impact factor: 8.237

Review 3.  Claudins and the modulation of tight junction permeability.

Authors:  Dorothee Günzel; Alan S L Yu
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

4.  Recurrent urinary tract infection and nephrocalcinosis: Answers.

Authors:  Robin Miller; Cheryl Sanchez-Kazi
Journal:  Pediatr Nephrol       Date:  2020-06-23       Impact factor: 3.714

5.  CLDN16 genotype predicts renal decline in familial hypomagnesemia with hypercalciuria and nephrocalcinosis.

Authors:  Martin Konrad; Jianghui Hou; Stefanie Weber; Jörg Dötsch; Jameela A Kari; Tomas Seeman; Eberhard Kuwertz-Bröking; Amira Peco-Antic; Velibor Tasic; Katalin Dittrich; Hammad O Alshaya; Rodo O von Vigier; Sabina Gallati; Daniel A Goodenough; André Schaller
Journal:  J Am Soc Nephrol       Date:  2007-11-14       Impact factor: 10.121

Review 6.  Familial hypomagnesemia with hypercalciuria and nephrocalcinosis.

Authors:  Mònica Vall-Palomar; Leire Madariaga; Gema Ariceta
Journal:  Pediatr Nephrol       Date:  2021-02-17       Impact factor: 3.714

7.  Genome-wide identification of copy number variation using high-density single-nucleotide polymorphism array in Japanese Black cattle.

Authors:  Shinji Sasaki; Toshio Watanabe; Shota Nishimura; Yoshikazu Sugimoto
Journal:  BMC Genet       Date:  2016-01-25       Impact factor: 2.797

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.